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ABSTRACT
The effects of ageing and skin type on Photodynamic Therapy (PDT) for different treatment methods have
been theoretically investigated. A multilayered Monte Carlo Radiation Transfer model is presented where both
daylight activated PDT and conventional PDT are compared. It was found that light penetrates deeper through
older skin with a lighter complexion, which translates into a deeper effective treatment depth. The effect of
ageing was found to be larger for darker skin types. The investigation further strengthens the usage of daylight
as a potential light source for PDT where effective treatment depths of about 2 mm can be achieved.
Keywords: Monte Carlo Radiation Transfer modelling of Photodynamic Therapy, Theoretical investigation of
Photodynamic therapy, Daylight Activated Photodynamic Therapy, Tissue Optics, Skin Ageing
1. INTRODUCTION
Photodynamic therapy (PDT) is an efficient treatment method for non-melanoma skin cancer (NMSC) and
precancerous skin lesions. The treatment method has proved very effective with a good cosmetic outcome and is
widely used for treating, for example, Basal Cell Carcinoma (BCC) and Aktinic Keratosis (AK). PDT combines
light, molecular oxygen and a photosensitive molecule to kill targeted tumour cells. Topical PDT uses a pro-
drug in the form of a cream (containing either 5-aminolaevulinic acid (ALA) or methyl aminolevulinate (MAL)),
which is converted within the cancerous cells to the photosensitive molecule Protoporphyrin IX (PpIX). The
high selective accumulation of PpIX in the tumour tissue leads to a selective treatment where the surrounding
healthy tissue is left relatively unaffected by the illuminating light.1–3
Light is absorbed by PpIX over a wide range of wavelengths (figure 1). Therefore it is possible to use different
types of treatment light sources. Here we investigate two different sources: an artificial light source (Aktilite,
Photocure ASA, Oslo, Norway4) and a natural light source (daylight, figure 1). Daylight has recently been
investigated as a potential light source for PDT.5 This treatment method allows for larger areas to be treated
and studies show that daylight activated PDT is associated with lower experienced pain and is the preferred
choice of treatment.6 Clinical studies around the world have shown that daylight PDT results in high efficacy
when applied to superficial skin lesions.7
During PDT the same treatment parameters are applied, independent of age and skin type. The aim of
this work is to investigate how the ageing of skin and different skin types affects the response during PDT.
Mathematical computer models are used to theoretically investigate the dynamics of the treatment and the
light interaction in the skin tissue.8,9 A multilayered three dimensional (3D) Monte Carlo Radiation Transfer
(MCRT) model is presented, where the properties within each separate layer vary to represent different ages and
skin types. Daylight PDT and conventional PDT are compared for these simulated treatment conditions.
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Figure 1: A) Spectral irradiance for daylight, where both the direct and diffuse component of the spectrum
are displayed. B) The spectrum for the Aktilite, which is a narrow band light source centred at 630 nm.
C) The absorption spectrum of PpIX for an assumed uniform initial number density of PpIX molecules of
1.62× 1014cm−3.12,13
1.1 Anatomy of skin and skin ageing
The human skin can be divided into several different layers with differing structure and optical properties.
The structure and components of the skin, and therefore also the function of the skin, varies with age, race,
gender and individual. The model presented here includes 5 separate layers of different tissue types (figure
2). The outermost layer is the epidermis which can be divided into two sub-layers; the stratum corneum (SC)
and the living epidermis (LE). The second main layer is the dermis, which can also be divided into two layers,
the papillary dermis (PD) and the reticular dermis (RD). The final layer that is included in the model is the
hypodermis (HD).10,11
The composition and structure of skin changes with age and appropriate care of elderly skin has great medical
importance.11 The ageing of skin is a complex procedure that is due to both endogenous and exogenous factors.
The endogenous factors include the physiological and chronological changes that affect skin as it ages. The
exogenous factors that contribute to ageing include ultraviolet (UV) radiation, toxins and infectious agents that
can lead to skin damage from DNA changes.14 Due to the medical importance it is important to understand
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Epidermis = Stratum Comeum +Living Epidermis
Dermis = Papillary Dermis + Reticular Dermis
Hypodermis
Figure 2: Representation of the five skin layers included in the theoretical model. The thickness and
blood/melanin content within the layers were adjusted accordingly to ageing and different skin types.
how ageing changes the response to light based treatment methods such as PDT. The work presented here
follows on from recently published work by Iglesias-Guitian et al15 where the main changes in composition and
structure due to ageing are included. The changes that are considered are thinning of the different skin layers
(approximately 6-16 % reduction per decade16) and reduction of the main absorbing components in the skin:
melanin (epidermis, approximately 8 % per decade17) and blood (dermis, approximately 6-10 % per decade18).
As well as ageing, different skin types, i.e. levels of pigmentation,19 are investigated where the melanin content
is adjusted appropriately.
2. METHODS
The radiative transfer equation (RTE) describes the photo-propagation through scattering media, such as skin
tissue.20 However, the equation is difficult to solve and therefore several approximations have been developed to
determine the light distribution within the medium. MCRT is a numerical technique that utilises the probabilistic
nature of photon interactions to determine the distribution of light in tissue and is therefore an appropriate tool
for simulating PDT.9,21 The MCRT code presented here has been developed from a publicly available code,
originally developed for applications in astronomy.12,22
2.1 Monte Carlo radiation transfer
The MCRT code tracks power packets (hereafter referred to as photons) through a 3D linear Cartesian grid
containing voxels, all with individual optical properties. This allows for complex 3D structures to be included in
the model. The photons are launched from the top of the grid and each photon is assigned an initial direction and
wavelength depending on the illuminating light source. The wavelengths are sampled such that the probability
distribution function of the irradiance, and therefore the illuminating spectra, are reproduced. The photons are
tracked until they are absorbed or scattered out of the simulation grid. As they travel through the grid they
contribute to counters that contain the information about the distribution and energy deposition of the photons
within the skin tissue.
2.2 Code validation
The code was validated using an experimental approach where the aim was to successfully reproduce real mea-
surements with the MCRT code. The fluorescence signal was obtained from a solution containing Coproporphyrin
III, distilled water and a varied concentration of Intralipid 20% (Fresenius Kabi, Germany). Intralipid is highly
scattering and is frequently used for studying light propagation through turbid media. The fluorescence signal
generated by the Coproporphyrin was recorded using an optical biopsy system (OBS), comprising a 405 nm laser
diode for excitation and a spectrometer (USB 2000, Ocean Optics) for detection. The same 600 µm diameterer
fiber probe is used for delivery of the excitation radiation and collection of the fluorescence signal.13 The exper-
imental set up was simulated using the MCRT code with appropriate optical properties and dimensions. A cube
with the dimensions 10 mm× 10 mm× 10 mm was simulated to represent the 10 mm× 10 mm cuvette used in the
lab. The illuminating and collecting region was simulated to match the diameter and numerical aperture of the
probe. It was assumed the anisotropy factor was constant for all wavelengths and was kept at 0.7.23 The albedo
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Figure 3: A) Scattering properties used in the simulations. The different concentrations corresponds to different
concentrations of Intralipid 20 %. B) Absorption spectrum of Coproporphyrin III. C) Fluorescence spectrum of
Coproporphyrin III in the range 500 nm to 750 nm.
for the Intralipid was assumed to be 0.999 due to its highly scattering features.24 The scattering properties of
the Intralipid are assumed to be scaled with the Intralipid concentration and the scattering is assumed to scale
equally over the wavelength range. The scattering properties for Intralipid 20 % are known25 and the scaling
factor used follow a power law function based on previous work24 (figure 3 a). The measured absorption of the
Coproporphyrin is shown in figure 3 b. The fluorescence spectrum, used in the MCRT code, was recorded using
OBS measurements from a sample of pure Coproporphyrin (figure 3 c). The measured and simulated fluorescence
of the Coproporphyrin III with varied concentration of Intralipid 20% produced using the MCRT code is shown
in figure 4. The change in the strength of the fluorescence signal is due to variations in the scattering properties.
An increased scattering causes more diffusion of the fluorescence signal. The collection geometry (diameter and
numerical aperture) remains the same in all cases so increasing the scattering causes a reduction in the overall
fluorescence signal as can be clearly seen in the experimental measurements (solid lines) in figure 4. This feature
due to the variation in Intralipid concentration was reproduced successfully by the developed MCRT code as
shown by the dashed lines in figure 4.
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Figure 4: Figure comparing experimental and theoretical results of the fluorescence signal, in arbitrary units
(a.u.), generated by Coproporphyrin III in a solution with varied concentration of Intralipid 20 %. A) 0.2 % of
Intralipid 20%, B) 0.5 % of Intralipid 20 % and C) 0.8 % of Intralipid 20 %.
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Table 1: Thicknesses for the investigated layers were included in the skin model to represent ageing.15
Thickness (mm)
Skin layer Age (years)
30 55 80
Stratum Corneum 0.02 0.02 0.02
Living Epidermis 0.08 0.07 0.06
Papillary Dermis 0.18 0.15 0.13
Reticular Dermis 1.82 1.55 1.27
Hypodermis 5.9 5.9 5.9
2.3 Code set up
The modelled skin tissue includes 5 separate layers where the thickness and composition of the different layers
were changed appropriately to represent ageing (table 1) for different skin types (table 2). The dimensions of
the simulation is set to be 5 mm x 5 mm x 5 mm and repeated boundary conditions were adopted to represent
a semi-infinite tissue slab. This model allows for photobleaching to be taken into account which changes the
distribution and concentration of PpIX during the light illumination. The PpIX photobleaching depends on both
the fluence rate, as well as the initial concentration of PpIX.26,27 The equation that describes the photobleaching
assumes an exponential decay of PpIX, which is wavelength dependent,5 and an unlimited oxygen supply. To
be able to quantify the treatment and to enable comparison of different treatment methods, the photodynamic
dose (PDD) is determined within the code. The PDD is defined as the number of absorbed photons (by the
photosensitiser) per cm3 . Following methods by Farrell et al the PDD was considered to be proportional to
the singlet oxygen production.27 A toxic threshold is included to determine the limit of effective treatment. A
threshold of 8.6 × 1017photons cm−3 has previously been determined from measurements of Photofrin in liver
tissue and has been adopted here for illustrative purposes to enable comparison between different treatment
conditions and previously established models.26
Table 2: Input parameters were used for the melanin and heamoglobin levels for the Living Epidermis (LE),
the Papillary Dermis (PD) and the Reticular Dermis (RD). These parameters were used to compute the optical
properties of the different skin layers to represent different ages and skin types. The hypodermal layer is assumed
to contain 5 % of haemoglobin. The blood oxygen saturation was assumed to be 75 %.15 30, 55 and 80 corresponds
to the age of the skin.
Melanin and heamoglobin volume fraction (%)
Skin type Melanin (LE) Heamoglobin (PD) Heamoglobin (RD)
30 55 80 30 55 80 30 55 80
I 1 0.8 0.6 6 3.6 1.2 4.5 2.73 0.9
II 3 2.4 1.8 6 3.6 1.2 4.5 2.73 0.9
III 5 4 3 6 3.6 1.2 4.5 2.73 0.9
IV 10 8 6 6 3.6 1.2 4.5 2.73 0.9
V 20 16 12 6 3.6 1.2 4.5 2.73 0.9
VI 30 24 18 6 3.6 1.2 4.5 2.73 0.9
2.4 Optical properties
To accurately model the light propagation through a medium, appropriate optical properties have to be assigned
to the different grid cells. For the skin model the relevant parameters were varied so that skin ageing and skin
types were appropriately represented (figure 5). To determine the absorption properties the main absorbing
components were included as well as background absorption from human flesh. This allowed for adjustment
of melanin and blood content to represent ageing and different skin types (table 2). The scattering properties
were determined from power law functions fitted to experimental data where both Mie and Rayleigh scattering
contributions are included.15,28–30
The Heyney-Greenstein phase function was adopted to describe the scattering directions within the skin
tissue,31 where the anisotropy factor, g = 0.62 + λ × 0.29 × 10−3 was adopted (λ in nm).32 The refractive
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Figure 5: Figure showing the optical properties adopted in the MCRT model to represent different ages and
skin types. A) Scattering coefficients for the three main layers. These are assumed to be the same both for
different skin types and different ages. B) The absorption coefficients at age 30 where the reticular dermis (RD),
papillary dermis (PD) and hypodermis (HD) are assumed to be constant for different skin types (not for different
ages). The Epidermal layers (both Stratum Corneum and Living Epidermis (LE)) are assumed to have uniform
absorption properties. However the melanin concentration will vary with skin type, and therefore the absorption
will change accordingly. Three skin types are displayed to demonstrate the effect of change in pigmentation. C)
The same absorption properties (same labelling), at an age of 55 years. D) Absorption coefficients at an age of
80 years.
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Figure 6: Figure showing fluence rate as a function of depth for different ages and skin types. Each figure
demonstrates the effect of ageing, where the optical properties for an age of 30 (no diamonds) and 80 (diamonds)
years are incorporated. Three wavelengths are investigates: 405 nm (solid line), 540 nm (dashed lines) and 630
nm (dotted line). A) Skin type I. B) Skin type III, C) Skin type VI .
index for the different layers were assumed to be uniform throughout the simulated region (n=1.38). The
initial distribution of the PpIX was also assumed to be uniform. As the concentration of PpIX changes, due to
photobleaching, the absorption properties of the PpIX change accordingly.
2.5 Light sources
The distribution of light under the surface of the skin depends on the spectrum and angular distribution of the
incident light. The work presented here adopts accepted methods to produce both direct and diffuse components
of the daylight.33,34 By decomposing the relative components it is possible to simulate daylight PDT for different
weather conditions. For an overcast day it is assumed that all of the illuminating light comes from the diffuse
component, whilst during a clear day only about 20 % of the illuminating spectrum is assumed to be diffuse
light. Here daylight activated PDT is investigated and compared with the conventional Aktilite light source.
The irradiance for the Aktilite is 82 mW cm−2, for daylight PDT during a clear summer day the irradiance was
determined to be 41 mW cm−2 and for an overcast summer day the irradiance was determined to be 8 mW cm−2.
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Figure 7: Photodynamic dose corresponding to 75 Jcm−2 for the different light sources at age A) 30, B) 55
and C) 80, for skin type I. Three light sources are compered: daylight for clear conditions (solid line), daylight
during overcast (dashed line) and the artificial light source, Aktilite (dotted line). The results show the change
in effective penetration depth with age where the horizontal line corresponds to the adopted toxic threshold.
These values for the sunlight are equivalent to those observed at noon in summer at a latitude of 56 degrees
North.5
3. RESULTS
The penetration of light depends strongly upon the illuminating wavelength due to the wavelength dependency
of the optical properties (figure 5). To demonstrate this the fluence rate was generated for three different
wavelengths (405, 540 and 630 nm), for different skin types (I,III and VI) at different ages (30, 55 and 80 years)
(figure 6). The fluence rate describes the distribution of light within the skin tissue and indicates the effect of the
investigated changes on the penetration depth. The fluence rate reduces with skin type number and increases
with age. The ageing reduces both the melanin content and blood content while the difference between different
skin type is only represented with a change in melanin content. Ageing of skin therefore has a larger effect on the
fluence rate at depth, however the change in melanin content is larger between different skin types than between
the ages presented here.
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Figure 8: Figure comparing the effect due to ageing of the skin for different skin types: A) I, B) III and C) VI.
Each figure contains the PDD at 75 Jcm−2 for three different ages (30,55 and 80 years) for the three different
light sources (daylight during clear conditions (solid line), daylight during overcast conditions (dashed) and
the Aktilite (dotted)). The most shallow contribution corresponds to the youngest age, while the the deepest
contribution corresponds to the oldest age (for all light sources investigated)
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The effects of skin type and ageing are summarised in figures 7 and 8. Figure 7 shows the PDD for a light
dose corresponding to 75 J cm−2, which is a typical light dose delivered for conventional PDT. The effects for skin
type I which is a common group affected by NMSC, are demonstrated. The effect of skin type, is investigated
for the full light dose (75 J cm−2), for different ages (30,55 and 80 years) and skin types (I, III, VI) (figure 8).
The effect of ageing, between 30 and 80 years, for skin type I corresponds to an effective treatment deapth of
approximately 0.5 mm. For skin type VI the same change corresponds to a approximately 1 mm of increase in
treatment depth.
4. DISCUSSION
The results shown in figure 4 show that the MCRT code can be used to reproduce experimental measurements.
The slight discrepancy between the theoretical and experimental results is due to uncertainty in the scattering
properties of the Intralipid across a wide range of wavelengths but nevertheless shows a good agreement between
out model and the experimental results.
Results shown in figures 6, 7 and 8 demonstrate the effect of skin ageing on light interaction with different
tissue types. The effective treatment depth is shown to increase with ageing and decrease with increasing skin
type classification number. The results suggest that daylight is a potentially useful light source for treating
superficial skin lesions for different ages and skin types, which agrees with previous clinical and theoretical
investigations. The deeper treatment depth is shown to be associated with older patients of lighter complexion,
which is also the most common patient group.
This investigation shows the dependence of treatment on different optical properties arising due to different
ages and skin type. It is clear from these results that it is important to incorporate appropriate optical properties
to enable accurate theoretical skin models to be developed. Since the range of published optical properties for
skin tissue is large,28,35 this type of investigation is important to demonstrate the effect of light interaction with
skin tissue as the optical properties are altered.
The model developed for this work only considers healthy tissue, where the same initial conditions for daylight
and conventional PDT are assumed. Due to the limited availability of optical properties of tumour tissue, tumour
structures have not been included. Future developments should include tumour tissue where the PpIX is confined.
Further developments of the MCRT code will lead to a more detailed investigation of the light interaction
within skin tissue for different treatment conditions. The model presented here does not take into account the
dryness, surface roughness or uneven pigmentation, which are other effects associated with ageing.11 However,
these are factors that could be included in a future study. The techniques demonstrated here are also applicable
in other areas where the range of ages and skin types is larger. One such area would be laser hair removal, where
it would be of both interest and relevance to study a larger range of patient groups.
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